Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKesson
US Department of Justice
QuintilesIMS
Covington
Johnson and Johnson
Accenture
Cantor Fitzgerald
Merck

Generated: February 23, 2018

DrugPatentWatch Database Preview

SPECTRACEF Drug Profile

« Back to Dashboard

When do Spectracef patents expire, and when can generic versions of Spectracef launch?

Spectracef is a drug marketed by Vansen Pharma and is included in one NDA.

The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefditoren pivoxil profile page.
Summary for SPECTRACEF
Drug patent expirations by year for SPECTRACEF
Pharmacology for SPECTRACEF

US Patents and Regulatory Information for SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKesson
AstraZeneca
US Army
Citi
Mallinckrodt
Federal Trade Commission
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot